BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15370157)

  • 61. An assessment of the validity of adolescent self-reported smoking using three biological indicators.
    Dolcini MM; Adler NE; Lee P; Bauman KE
    Nicotine Tob Res; 2003 Aug; 5(4):473-83. PubMed ID: 12959785
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Validating a dipstick method for detecting recent smoking.
    Gariti P; Rosenthal DI; Lindell K; Hansen-Flaschen J; Shrager J; Lipkin C; Alterman AI; Kaiser LR
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1123-5. PubMed ID: 12376520
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial.
    Rennard SI; Glover ED; Leischow S; Daughton DM; Glover PN; Muramoto M; Franzon M; Danielsson T; Landfeldt B; Westin A
    Nicotine Tob Res; 2006 Aug; 8(4):555-64. PubMed ID: 16920653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative analysis of the effects of hubble-bubble (Sheesha) and cigarette smoking on respiratory and metabolic parameters in hubble-bubble and cigarette smokers.
    Al Mutairi SS; Shihab-Eldeen AA; Mojiminiyi OA; Anwar AA
    Respirology; 2006 Jul; 11(4):449-55. PubMed ID: 16771915
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantification and chemical markers of tobacco-exposure.
    Prignot J
    Eur J Respir Dis; 1987 Jan; 70(1):1-7. PubMed ID: 3545884
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Cotinine in urine of mother and their newborn and in cord serum and placenta as a biomarker of foetal exposure to tobacco smoke].
    Florek E; Breborowicz GH; Lechowicz W; Wachowiak A; Basior A; Wolna M; Hubert A; Seńczuk M
    Przegl Lek; 2006; 63(10):900-6. PubMed ID: 17288180
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of smoking status in patients with peripheral arterial disease.
    Hobbs SD; Wilmink AB; Adam DJ; Bradbury AW
    J Vasc Surg; 2005 Mar; 41(3):451-6. PubMed ID: 15838479
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sex differences in effects of cigarette smoking and 24-hr abstinence on plasma arginine vasopressin.
    Guaderrama MM; Corwin EJ; Kapelewski CH; Klein LC
    Addict Behav; 2011 Nov; 36(11):1106-9. PubMed ID: 21752550
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cotinine effects on nicotine metabolism.
    Zevin S; Jacob P; Benowitz N
    Clin Pharmacol Ther; 1997 Jun; 61(6):649-54. PubMed ID: 9209247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical correlation between the consumption of nicotine and cotinine concentrations in urine and serum by competitive enzyme-linked immunosorbent assay.
    Ziegler UE; Kauczok J; Dietz UA; Reith HB; Schmidt K
    Pharmacology; 2004 Dec; 72(4):254-9. PubMed ID: 15539886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deficient C-oxidation of nicotine.
    Benowitz NL; Jacob P; Sachs DP
    Clin Pharmacol Ther; 1995 May; 57(5):590-4. PubMed ID: 7768082
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Accuracy of self-reported smoking status among participants in a chemoprevention trial.
    Martínez ME; Reid M; Jiang R; Einspahr J; Alberts DS
    Prev Med; 2004 Apr; 38(4):492-7. PubMed ID: 15020184
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [What are the markers of tobacco smoking?].
    Gourlain H; Galliot-Guilley M
    J Gynecol Obstet Biol Reprod (Paris); 2005 Apr; 34 Spec No 1():3S154-70. PubMed ID: 15980785
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitation of continine in sera of smokers.
    Langone JJ; Van Vunakis H
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):21-8. PubMed ID: 1124319
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Usefulness of biological markers in the evaluation of smoking at the first visit of a smoking cessation program].
    Underner M; Ingrand P; Favreau M; Mura P; Meurice JC
    Rev Mal Respir; 2004 Sep; 21(4 Pt 1):705-10. PubMed ID: 15536371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Usefulness of biological markers in evaluation of smoking].
    Larramendy C; Diviné C; Asnafi-Farhang S; Lagrue G
    Pathol Biol (Paris); 2004 Apr; 52(3):164-72. PubMed ID: 15063936
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Automated homogeneous immunoassay analysis of cotinine in urine.
    Niedbala RS; Haley N; Kardos S; Kardos K
    J Anal Toxicol; 2002 Apr; 26(3):166-70. PubMed ID: 11991533
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Smoking cessation increases gingival blood flow and gingival crevicular fluid.
    Morozumi T; Kubota T; Sato T; Okuda K; Yoshie H
    J Clin Periodontol; 2004 Apr; 31(4):267-72. PubMed ID: 15016254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Does breath carbon monoxide measure nicotine dependence?
    Kapusta ND; Pietschnig J; Plener PL; Blüml V; Lesch OM; Walter H
    J Addict Dis; 2010 Oct; 29(4):493-9. PubMed ID: 20924886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.